Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
CTKB
— Cytek Biosciences, Inc.
NASDAQ
FULL STOCK PAGE →
Q3 2025 Earnings Call Summary
NOV 5, 2025
REVENUE
$52.3M
+14.7%
NET MARGIN
-10.5%
+1.8 PTS
EPS
-$0.04
+2.5%
FREE CASH FLOW
-$4.6M
-209.9%
No summary has been written for this call yet.
← NEWER CALL
CALL 4 OF 4
OLDER CALL →